RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Role of Yttrium-90 Ibritumomab Tiuxetan (Zevalin®) in Inducing and Maintaining Complete Molecular Response in B Non Hodgkin’s Lymphoma Patients in Clinical Complete Remission after Chemotherapy Regimen.
2007-01-01 Orciuolo, E; Buda, G; Galimberti, Sara; Boni, G; Cecconi, N; Petrini, M.
SAFETY AND EFFICACY OF 90 Y IBRITUMUMAB TIUXETAN (ZEVALIN) FOR UNTREATED FOLLICULAR NON HODGKIN'S LYMPHOMA (FL) PATIENTS. ITALIAN MULTICENTRIC TRIAL.
2011-01-01 Pica, Gm; Nati, S; Vitolo, U; Botto, B; Galimberti, Sara; Zinzani, Pl; Cascavilla, N; Petrini, Mario; Carella, A. M.
Safety and Efficacy of 90Y Ibritumomab Tiuxetan (Zevalin®) for Untreated FollicularNon-Hodgkin's Lymphoma (FL) Patients, An Italian Cooperative Study
2011-01-01 Pica, G; Nati, S; Vitolo, U; Galimberti, Sara; Zinzani, Pl; Cascavilla, N; Petrini, Mario; Carella, A. M.
Safety and Efficacy of Pegylated Liposomal Doxorubicin In Combination with Dexamethasone and Bortezomib (VMD) or Lenalidomide (RMD) In Multiple Myeloma Refractory/Relapsed Patients
2010-01-01 Buda, G; Orciuolo, E; Galimberti, Sara; Pelosini, M; Petrini, Mario
SAHA INHIBITS PROLIFERATION AND INDUCES APOPTOSIS IN A MEGAKARYOBLASTIC CELL LINE AND SYNERGISTICALLY INTERCATCS WITH THE PORTEASOME INHIBITOR BORTEZOMIB.
2007-01-01 Canestraro, M; Maffei, R; Canestraro, M; Maffei, R; Marasca, R; Galimberti, Sara; Simonetti, F; Sordi, E; Focosi, D; Cannizzo, E; Torelli, G; Petrini, Mario
TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME
2013-01-01 Galimberti, Sara; Ciabatti, Elena; Grassi, Susanna; Mr, Metelli; Guerrini, Francesca; Paggiaro, PIER LUIGI; S., Bombardieri; Petrini, Mario; Baldini, Chiara
THE C.480C>G POLYMORPHISM OF HOCT1 TRANSPORTER INFLUENCES IMATINIB CLEARANCE IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA
2013-01-01 Galimberti, Sara; Polillo, Marialuisa; M., Capecchi; G., Cervetti; C., Baratè; Guerrini, Francesca; Fontanelli, Giulia; Arici, Roberta; Ciabatti, Elena; Grassi, Susanna; Bocci, Guido; Danesi, Romano; Petrini, Mario; DI PAOLO, Antonello
THE HOCT1/ABCB1 DIPLOTYPE IS ASSOCIATED WITH COMPLETE CYTOGENETIC RESPONSE AND TOLERABILITY TO IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA
2016-01-01 Galimberti, Sara; Galeotti, L.; Ceccherini, F.; Domingo, D.; Laurino, M.; Barate, C; Ricci, F; Grassi, S.; Guerrini, F; Fava, C; D'Avolio, A; Cervetti, G.; Fontanelli, G.; Saglio, G.; Cornolti, Fulvio; Petrini, Mario; Arrigoni, E; DI PAOLO, Antonello
The Proteasome Inhibitor Bortezomib and Histone Deacetylase Inhibitor SAHA Sinergistically Inhibit Proliferation and Induce Apoptosis of Megakaryoblastic MO7-e Cells.
2006-01-01 Galimberti, Sara; Mattii, Letizia; Canestraro, Martina; Pacini, Simone; Fazzi, R; Orciuolo, E; Collecchi, P; Ami, S; Presutti, F; Brugiatelli, M; Petrini, Mario
The Proteasome Inhibitor Bortezomib and Histone Deacetylase Inhibitor SAHA Sinergistically Inhibit Proliferation and Induce Apoptosis of Megakaryoblastic MO7-e Cells.
2006-01-01 Galimberti, Sara; Canestraro, M; Pacini, S; Fazzi, R; Orciuolo, E; Mattii, Letizia; Collecchi, P; Sen, A; Presutti, F; Brugiatelli, M; Petrini, Mario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Role of Yttrium-90 Ibritumomab Tiuxetan (Zevalin®) in Inducing and Maintaining Complete Molecular Response in B Non Hodgkin’s Lymphoma Patients in Clinical Complete Remission after Chemotherapy Regimen. | 1-gen-2007 | Orciuolo, E; Buda, G; Galimberti, Sara; Boni, G; Cecconi, N; Petrini, M. | |
| SAFETY AND EFFICACY OF 90 Y IBRITUMUMAB TIUXETAN (ZEVALIN) FOR UNTREATED FOLLICULAR NON HODGKIN'S LYMPHOMA (FL) PATIENTS. ITALIAN MULTICENTRIC TRIAL. | 1-gen-2011 | Pica, Gm; Nati, S; Vitolo, U; Botto, B; Galimberti, Sara; Zinzani, Pl; Cascavilla, N; Petrini, Mario; Carella, A. M. | |
| Safety and Efficacy of 90Y Ibritumomab Tiuxetan (Zevalin®) for Untreated FollicularNon-Hodgkin's Lymphoma (FL) Patients, An Italian Cooperative Study | 1-gen-2011 | Pica, G; Nati, S; Vitolo, U; Galimberti, Sara; Zinzani, Pl; Cascavilla, N; Petrini, Mario; Carella, A. M. | |
| Safety and Efficacy of Pegylated Liposomal Doxorubicin In Combination with Dexamethasone and Bortezomib (VMD) or Lenalidomide (RMD) In Multiple Myeloma Refractory/Relapsed Patients | 1-gen-2010 | Buda, G; Orciuolo, E; Galimberti, Sara; Pelosini, M; Petrini, Mario | |
| SAHA INHIBITS PROLIFERATION AND INDUCES APOPTOSIS IN A MEGAKARYOBLASTIC CELL LINE AND SYNERGISTICALLY INTERCATCS WITH THE PORTEASOME INHIBITOR BORTEZOMIB. | 1-gen-2007 | Canestraro, M; Maffei, R; Canestraro, M; Maffei, R; Marasca, R; Galimberti, Sara; Simonetti, F; Sordi, E; Focosi, D; Cannizzo, E; Torelli, G; Petrini, Mario | |
| TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME | 1-gen-2013 | Galimberti, Sara; Ciabatti, Elena; Grassi, Susanna; Mr, Metelli; Guerrini, Francesca; Paggiaro, PIER LUIGI; S., Bombardieri; Petrini, Mario; Baldini, Chiara | |
| THE C.480C>G POLYMORPHISM OF HOCT1 TRANSPORTER INFLUENCES IMATINIB CLEARANCE IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA | 1-gen-2013 | Galimberti, Sara; Polillo, Marialuisa; M., Capecchi; G., Cervetti; C., Baratè; Guerrini, Francesca; Fontanelli, Giulia; Arici, Roberta; Ciabatti, Elena; Grassi, Susanna; Bocci, Guido; Danesi, Romano; Petrini, Mario; DI PAOLO, Antonello | |
| THE HOCT1/ABCB1 DIPLOTYPE IS ASSOCIATED WITH COMPLETE CYTOGENETIC RESPONSE AND TOLERABILITY TO IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA | 1-gen-2016 | Galimberti, Sara; Galeotti, L.; Ceccherini, F.; Domingo, D.; Laurino, M.; Barate, C; Ricci, F; Grassi, S.; Guerrini, F; Fava, C; D'Avolio, A; Cervetti, G.; Fontanelli, G.; Saglio, G.; Cornolti, Fulvio; Petrini, Mario; Arrigoni, E; DI PAOLO, Antonello | |
| The Proteasome Inhibitor Bortezomib and Histone Deacetylase Inhibitor SAHA Sinergistically Inhibit Proliferation and Induce Apoptosis of Megakaryoblastic MO7-e Cells. | 1-gen-2006 | Galimberti, Sara; Mattii, Letizia; Canestraro, Martina; Pacini, Simone; Fazzi, R; Orciuolo, E; Collecchi, P; Ami, S; Presutti, F; Brugiatelli, M; Petrini, Mario | |
| The Proteasome Inhibitor Bortezomib and Histone Deacetylase Inhibitor SAHA Sinergistically Inhibit Proliferation and Induce Apoptosis of Megakaryoblastic MO7-e Cells. | 1-gen-2006 | Galimberti, Sara; Canestraro, M; Pacini, S; Fazzi, R; Orciuolo, E; Mattii, Letizia; Collecchi, P; Sen, A; Presutti, F; Brugiatelli, M; Petrini, Mario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 101
- 1 Contributo su Rivista::1.5 Abst... 101
Data di pubblicazione
- 2010 - 2020 48
- 2000 - 2009 49
- 1990 - 1999 4
Rivista
- BLOOD 35
- HAEMATOLOGICA 33
- BONE MARROW TRANSPLANTATION 13
- HAEMATOLOGICA 7
- BONE MARROW TRANSPLANTATION 4
- AMERICAN JOURNAL OF CLINICAL ONCO... 2
- ANNALS OF THE RHEUMATIC DISEASES 1
- BLOOD REVIEWS 1
- CYTOMETRY. PART A 1
- EUROPEAN SURGICAL RESEARCH 1
Keyword
- immune reconstitution 3
- immunotherapy 2
- T-lymphocytes 2
- thymus 2
- zinc 2
- 10 patients died all due to progr... 1
- 27 a partial remission considerin... 1
- 28 with 70 mg/m2 and 5 with 120 m... 1
- 3 relapsed and 28 with disease un... 1
- 31 in continuous complete remission 1
Lingua
- eng 71
Accesso al fulltext
- no fulltext 96
- open 4
- restricted 1